Preoperative radiation improved T-cell infiltration in patients with HR+ HER2- breast cancer when administered in combination ...
Presented at 2025 SABCS, the phase III lidERA trial showed that oral SERD giredestrant reduced the risk of invasive disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback